watch this drop today. I do agree with a rerate but not to this proportion. Sales to the US wont save it given it (the product) has already been sold to most of the world and the market cap had only diminished. The US isnt some magic wand but it will help with revenue somewhat..
some logic: https://www.dhakatribune.com/financial-markets/2023/07/03/lumos-diagnostics-ldx-up-500-on-fda-authorisation---this-could-be-excessive
Good luck day traders.
Ann: Lumos Receives US FDA Clearance for FebriDx, page-265
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
-0.002(5.71%) |
Mkt cap ! $24.61M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.5¢ | 3.3¢ | $26.02K | 753.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 201223 | 3.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 320000 | 2 |
View Market Depth
| Last trade - 14.52pm 06/11/2024 (20 minute delay) ? |
| LDX (ASX) Chart |